Chemoinformaics analysis of 2,6,6-Trimethyl-4-(tert-butylperoxy)bicyclo[3.1.1]hepta-2-ene
| Molecular Weight | 224.344 | nRot | 2 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 8 |
| Exact Molecular Weight | 224.178 | nRing | 3 |
| Solubility: LogS | -4.731 | nHRing | 0 |
| Solubility: LogP | 4.127 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 40.987 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.404 |
| Synth | 4.999 |
| Natural Product Likeliness | 2.062 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.881 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.461 |
| MDCK | 0.000016 |
| BBB | 0.916 |
| PPB | 0.843357 |
| VDSS | 1.675 |
| FU | 0.167097 |
| CYP1A2-inh | 0.123 |
| CYP1A2-sub | 0.413 |
| CYP2c19-inh | 0.362 |
| CYP2c19-sub | 0.93 |
| CYP2c9-inh | 0.347 |
| CYP2c9-sub | 0.56 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.669 |
| CYP3a4-inh | 0.073 |
| CYP3a4-sub | 0.348 |
| CL | 9.923 |
| T12 | 0.105 |
| hERG | 0.004 |
| Ames | 0.007 |
| ROA | 0.038 |
| SkinSen | 0.035 |
| Carcinogencity | 0.102 |
| EI | 0.384 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.897059 |